Angiology最新文献_第4页

Letter to the Editor: Can Mean Platelet Volume/Platelet Count Ratio be Implemented into Daily Clinical Decision Making Process? 致编辑的信：平均血小板体积/血小板计数比值能否应用于日常临床决策过程？

IF 2.6 3区医学

Angiology Pub Date : 2024-10-25 DOI: 10.1177/00033197241296467

Orhan Batur Şahin, Serkan Ünlü, Özden Seçkin Göbüt

引用次数: 0

Letter: Endovascular Treatment in Patients With Peripheral Artery Disease-Not Much of a Help Without Optimal Medical Treatment. 信：外周动脉疾病患者的血管内治疗--在没有最佳医疗手段的情况下作用不大。

IF 2.6 3区医学

Angiology Pub Date : 2024-10-17 DOI: 10.1177/00033197241292848

Christos Rammos, Nasser Malyar, Grigorios Korosoglou

引用次数: 0

Letter: Atherogenic Index of Plasma and Cardiovascular Mortality. 信：血浆致动脉粥样硬化指数与心血管死亡率

IF 2.6 3区医学

Angiology Pub Date : 2024-10-08 DOI: 10.1177/00033197241290932

Mesut Engin, Abdurrahman Demirel

引用次数: 0

Evolving Role of Coronary Collaterals in STEMI Outcomes: A Comparative Analysis of Pandemic and Post-Pandemic Phases. 冠状动脉袢在 STEMI 结果中不断演变的作用：大流行阶段和大流行后阶段的比较分析。

IF 2.6 3区医学

Angiology Pub Date : 2024-10-02 DOI: 10.1177/00033197241288662

Ozgur Ulas Ozcan, Muhammed Bora Demircelik, Aykun Hakgor, Atakan Dursun, Arzu Yazar, Aysel Akhundova, Beytullah Cakal, Oguz Karaca, Bilal Boztosun

{"title":"Evolving Role of Coronary Collaterals in STEMI Outcomes: A Comparative Analysis of Pandemic and Post-Pandemic Phases.","authors":"Ozgur Ulas Ozcan, Muhammed Bora Demircelik, Aykun Hakgor, Atakan Dursun, Arzu Yazar, Aysel Akhundova, Beytullah Cakal, Oguz Karaca, Bilal Boztosun","doi":"10.1177/00033197241288662","DOIUrl":"https://doi.org/10.1177/00033197241288662","url":null,"abstract":"Acute ST-elevation myocardial infarction (STEMI) is a critical condition where coronary collaterals can mitigate myocardial damage. The Coronavirus Disease 2019 (COVID-19) pandemic introduced unique challenges in STEMI management, potentially affecting outcomes. This study evaluates the efficacy of coronary collaterals during the pandemic compared to the post-pandemic period. A review of 1465 STEMI patients treated at a high-volume tertiary care center from April 2020 to December 2022 was conducted. Collaterals were assessed using the Rentrop classification. In-hospital mortality and 1-year major adverse cardiac events (MACE) were analyzed based on collateral status and timeframes. During the pandemic, there was a higher incidence of robust collaterals (28.2% vs 23.2%, P = .04), but they were less protective, with similar in-hospital mortality (14.4% vs 8.1%, P = .07) and 1-year MACE rates (21.9% vs 30.4%, P = .09) across groups. Post-pandemic, robust collaterals showed significant protective effects with reduced in-hospital mortality (3.6% vs 7.4%, P = .04) and 1-year MACE rates (17.1% vs 24.9%, P = .03). These findings highlight a dynamic role of collaterals in STEMI management, with the pandemic impairing their functionality. This underscores the need for adaptive STEMI care strategies, especially during global health crises.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"33197241288662"},"PeriodicalIF":2.6,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Letter: Prognostic Nutritional Index as a Novel Biomarker of Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome. 信：作为急性冠状动脉综合征患者造影剂诱发肾病的新型生物标志物的预后营养指数

IF 2.6 3区医学

Angiology Pub Date : 2024-10-01 Epub Date: 2023-08-24 DOI: 10.1177/00033197231198676

Ya Li, Tai Li, Lei Wang

引用次数: 0

Near-Infrared Fluorescence Imaging With Indocyanine Green to Predict Clinical Outcome After Revascularization in Lower Extremity Arterial Disease. 用吲哚菁绿近红外荧光成像预测下肢动脉疾病血管再通后的临床效果

IF 2.6 3区医学

Angiology Pub Date : 2024-10-01 Epub Date: 2023-06-26 DOI: 10.1177/00033197231186096

Floris P Tange, Pim van den Hoven, Jan van Schaik, Abbey Schepers, Koen E A van der Bogt, Catharina S P van Rijswijk, Hein Putter, Alexander L Vahrmeijer, Jaap F Hamming, Joost R van der Vorst

{"title":"Near-Infrared Fluorescence Imaging With Indocyanine Green to Predict Clinical Outcome After Revascularization in Lower Extremity Arterial Disease.","authors":"Floris P Tange, Pim van den Hoven, Jan van Schaik, Abbey Schepers, Koen E A van der Bogt, Catharina S P van Rijswijk, Hein Putter, Alexander L Vahrmeijer, Jaap F Hamming, Joost R van der Vorst","doi":"10.1177/00033197231186096","DOIUrl":"10.1177/00033197231186096","url":null,"abstract":"Contemporary quality control methods are often insufficient in predicting clinical outcomes after revascularization in lower extremity arterial disease (LEAD) patients. This study evaluates the potential of near-infrared fluorescence imaging with indocyanine green to predict the clinical outcome following revascularization. Near-infrared fluorescence imaging was performed before and within 5 days following the revascularization procedure. Clinical improvement was defined as substantial improvement of pain free walking distance, reduction of rest- and/or nocturnal pain, or tendency toward wound healing. Time-intensity curves and 8 perfusion parameters were extracted from the dorsum of the treated foot. The quantified postinterventional perfusion improvement was compared within the clinical outcome groups. Successful near-infrared fluorescence imaging was performed in 72 patients (76 limbs, 52.6% claudication, 47.4% chronic limb-threatening ischemia) including 40 endovascular- and 36 surgical/hybrid revascularizations. Clinical improvement was observed in 61 patients. All perfusion parameters showed a significant postinterventional difference in the clinical improvement group (P-values <.001), while no significant differences were seen in the group without clinical improvement (P-values .168-.929). Four parameters demonstrated significant differences in percentage improvement comparing the outcome groups (P-values within .002-.006). Near-infrared fluorescence imaging has promising additional value besides clinical parameters for predicting the clinical outcome of revascularized LEAD patients.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"884-892"},"PeriodicalIF":2.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9685367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cardiovascular and Venous Thromboembolic Events After Hospital Discharge for COVID-19: A Prospective Single Center Study. COVID-19 出院后的心血管和静脉血栓栓塞事件：一项前瞻性单中心研究

IF 2.6 3区医学

Angiology Pub Date : 2024-10-01 Epub Date: 2023-08-19 DOI: 10.1177/00033197231196175

S Soudet, D Basille, H Carette, M Mercier, C Andrejak, M-A Sevestre

{"title":"Cardiovascular and Venous Thromboembolic Events After Hospital Discharge for COVID-19: A Prospective Single Center Study.","authors":"S Soudet, D Basille, H Carette, M Mercier, C Andrejak, M-A Sevestre","doi":"10.1177/00033197231196175","DOIUrl":"10.1177/00033197231196175","url":null,"abstract":"Coronavirus disease 2019 (COVID-19) is associated with an increase in venous thrombotic and cardiovascular (CV) events has been reported during hospitalization. No systematic ultrasound follow-up to evaluate sequelae was ever that took place carried out prospectively associated with the evaluation of CV morbidity-mortality at 3 months post-discharge. Consecutive patients hospitalized for COVID-19 in the Amiens-Picardie University Hospital between 1st February and 31st August 2020 were included. The primary objective was the thrombosis incidence at 3 months after hospital discharge. Thrombosis was defined as either venous thromboembolism (VTE) or a CV event (CVE: myocardial infarction (MI), stroke or peripheral arterial disease). A secondary objective was to determine the risk factors for thrombotic events. We included 498 patients (279 men; 56%) of median age 66 (55-76) years. The primary composite outcome occurred in 27 patients (5.4%); 19 patients (3.8%) presented a CVE (stroke, n = 5; MI, n = 9; and peripheral arterial disease, n = 5). Two patients (0.8%) presented VTE. Six patients (1.2%) died. In multivariate analysis, a previous CVE was associated with thrombosis (OR 3.11; 95% CI 1.17-8.24). COVID-19 was significantly associated with thrombotic events post hospital discharge. Special attention should be given to CVE in the follow-up of patients with a previous thrombotic event.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"893-898"},"PeriodicalIF":2.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10026028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Autologous Bone Marrow Stem Cells in Patients With Critical Limb Ischaemia not Eligible for Revascularization: A Single Centre Experience. 自体骨髓干细胞治疗不符合血运重建条件的危重肢体缺血性疾病患者：单中心经验。

IF 2.6 3区医学

Angiology Pub Date : 2024-10-01 Epub Date: 2023-09-20 DOI: 10.1177/00033197231190512

Pietro Modugno, Savino Cilla, Enrico Maria Centritto, Veronica Picone, Maurizio Maiorano, Mariangela Amatuzio, Maria Pia Petrilli, Vincenzo Fraticelli, Carlo Maria De Filippo, Eugenio Caradonna, Franco Alberto Codispoti, Massimo Massetti, Yamume Tshomba

{"title":"Autologous Bone Marrow Stem Cells in Patients With Critical Limb Ischaemia not Eligible for Revascularization: A Single Centre Experience.","authors":"Pietro Modugno, Savino Cilla, Enrico Maria Centritto, Veronica Picone, Maurizio Maiorano, Mariangela Amatuzio, Maria Pia Petrilli, Vincenzo Fraticelli, Carlo Maria De Filippo, Eugenio Caradonna, Franco Alberto Codispoti, Massimo Massetti, Yamume Tshomba","doi":"10.1177/00033197231190512","DOIUrl":"10.1177/00033197231190512","url":null,"abstract":"We evaluated the use of autologus bone marrow stem cells transplantation in patients with critical limb ischaemia (CLI) not eligible for revascularization. Eighty consecutive patients candidate to amputation were enrolled in a single-centre retrospective study. The primary endpoint was defined as the amputation-free rate from stem cells transplantation. Secondary endpoints were the evaluation of transcutaneous oximetry and its predictive potential for probability of amputation and the evaluation of rest pain. Ankle brachial index, transcutaneous oxygen (TcpO2) and radiological imaging were performed at the enrolment and during the follow-up times. All patients were treated with auto transplant of bone marrow stem cells. Two patients died due to acute renal and acute respiratory failures. 19 patients were amputated from the thigh or leg. In total, 59 of 80 patients intended to thigh amputation saved the limb, preserving the plantar support. TcpO2 was found a predictive metric with an AUC equal to .763, and a threshold for a risk of amputation of 10% and 5% at the values ≤22.7 and ≤26.9 mmHg, respectively. Auto transplant of bone marrow stem cells seems to be a safe and an efficient option for CLI not eligible to revascularizzation.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"865-873"},"PeriodicalIF":2.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41099589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Association Between Inflammatory Biomarkers and Contrast-induced Acute Kidney Injury in ACS Patients Undergoing Percutaneous Coronary Intervention: A Cross-sectional Study. 接受经皮冠状动脉介入治疗的 ACS 患者的炎症生物标志物与对比剂诱发的急性肾损伤之间的关系：一项横断面研究。

IF 2.6 3区医学

Angiology Pub Date : 2024-10-01 Epub Date: 2023-06-19 DOI: 10.1177/00033197231185445

Zhanneng Yang, Yong Qiao, Dong Wang, Gaoliang Yan, Chengchun Tang

{"title":"Association Between Inflammatory Biomarkers and Contrast-induced Acute Kidney Injury in ACS Patients Undergoing Percutaneous Coronary Intervention: A Cross-sectional Study.","authors":"Zhanneng Yang, Yong Qiao, Dong Wang, Gaoliang Yan, Chengchun Tang","doi":"10.1177/00033197231185445","DOIUrl":"10.1177/00033197231185445","url":null,"abstract":"The present study aimed to evaluate the predictive role of inflammatory biomarkers in the development of contrast-induced acute kidney injury (CI-AKI) in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). The inflammatory biomarkers assessed were: platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (dNLR), neutrophil-to-lymphocyte*platelet ratio (NLPR), systemic inflammatory index (SII), and systemic inflammation response index (SIRI). Overall, 950 patients undergoing PCI were enrolled. The frequency of CI-AKI was 15.2% (n = 144). The levels of NLR, MLR, NLPR, SII, and SIRI were higher in the CI-AKI group than in the Non-CI-AKI group (P < .05). The addition of NLR ≥2.96, dNLR ≥2.08, NLPR ≥.012, SII ≥558.04, and SIRI ≥1.13 to the Mehran score model significantly increased the area under the curve (P < .05). Multivariable logistic regression analyses indicated that inflammatory biomarkers were significantly associated with CI-AKI, including NLR ≥2.96 (OR = 1.588, P = .017), dNLR ≥2.08 (OR = 1.686, P = .007), SII ≥558.04 (OR = 1.521, P = .030), and SIRI ≥1.13 (OR = 1.601, P = .017). Therefore, inflammation is associated with the development of CI-AKI, and preoperative hematological inflammatory markers could predict the risk of CI-AKI in ACS patients undergoing PCI.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"831-840"},"PeriodicalIF":2.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9717824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Associations of Serum Apolipoprotein A1 and High Density Lipoprotein Cholesterol With Glucose Level in Patients With Coronary Artery Disease. 冠心病患者血清载脂蛋白 A1 和高密度脂蛋白胆固醇与血糖水平的关系

IF 2.6 3区医学

Angiology Pub Date : 2024-10-01 Epub Date: 2023-07-03 DOI: 10.1177/00033197231187228

Hongli Dong, Nan Lu, Ping Hu, Jie Wang

{"title":"Associations of Serum Apolipoprotein A1 and High Density Lipoprotein Cholesterol With Glucose Level in Patients With Coronary Artery Disease.","authors":"Hongli Dong, Nan Lu, Ping Hu, Jie Wang","doi":"10.1177/00033197231187228","DOIUrl":"10.1177/00033197231187228","url":null,"abstract":"This study determined the associations of apolipoprotein A1 (ApoA1), high-density lipoprotein cholesterol (HDL-C), and HDL-C/ApoA1 ratio with fasting blood glucose (FBG) and evaluated the mediating effects of high-sensitivity C-reactive protein (hsCRP) and body mass index (BMI). A cross-sectional study with 4805 coronary artery disease (CAD) patients was performed. In multivariable analyses, higher ApoA1, HDL-C, and HDL-C/ApoA1 ratio were associated with significantly lower FBG level (Q [quartile] 4 vs Q1: 5.67 vs 5.87 mmol/L for ApoA1; 5.64 vs 5.98 mmol/L for HDL-C; 5.63 vs 6.01 mmol/L for HDL-C/ApoA1 ratio). Moreover, inverse associations of ApoA1, HDL-C, and HDL-C/ApoA1 ratio with abnormal FBG (AFBG) were found with odd ratios (95% confidence interval) of .83 (.70-.98), .60 (.50-.71), and .53 (.45-.64) in Q4 compared with Q1. Path analyses indicated that \"ApoA1 (or HDL-C)-FBG\" associations were mediated by hsCRP and \"HDL-C-FBG\" association was mediated by BMI. Our data suggested that higher ApoA1, HDL-C, and HDL-C/ApoA1 ratio were favorably associated with a lower FBG level in CAD patients and these associations might be mediated by hsCRP or BMI. Collectively, higher concentrations of ApoA1, HDL-C, and HDL-C/ApoA1 ratio might decrease the risk of AFBG.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"849-856"},"PeriodicalIF":2.6,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9737657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0